Journal of Capital Medical University ›› 2015, Vol. 36 ›› Issue (3): 345-353.doi: 10.3969/j.issn.1006-7795.2015.03.003

Previous Articles     Next Articles

Comparative study on effect of surgery for moderate/severe ischemic mitral regurgitation

Yin Bo, Wang Xiaolong, Liu Yuyong, Zheng Tie, Gong Ming, Li Haiyang, Liu Ou, Guan Xinliang, Peng Xiaole, Jiang Wenjian, Huang Qi, Guo Dong, Zhang Hongjia   

  1. Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing Aortic Disease Medical Center, Beijing Engineering Research Center for Vascular Prostheses, Beijing 100029, China
  • Received:2015-03-18 Online:2015-06-21 Published:2015-06-15
  • Supported by:

    This study was supported by National Natural Science Foundation of China (81170283, 81470580), Natural Science Foundation of Beijing(7112041), New Century Excellent Talents of Ministry of Education(NCET-11-0899).

Abstract:

Objective This study aimed to compare effects of surgeries for mitral valve repair and replacement in patients with ischemic mitral regurgitation (IMR), and to determine whether mitral valve operation in different ways will have an impact on patient mortality, survival rate and prognosis. Methods This study included a total of 296 patients, all had moderate to severe chronic ischemic mitral regurgitation.The patients were divided into two groups; on the basis of coronary artery bypass grafting, group 1 received mitral valve repair and group 2 received mitral valve replacement. The patients were followed up for the long term survival rate and heart function, readmission. Finally, the data were analyzed through statistical method. Results 1) No statistically significant differences in baseline data were found between the two groups of patients, and operation details; 2)The operation mortality: No significant difference was found between mitral valve repair group and mitral replacement group (P=0.607);3) Long term survival curve: mitral valve replacement was better than mitral valve repair on the whole (P <0.05); survival rate of mitral valve replacement group patients was better than that of mitral valve repair group when left ventricular ejection fraction was over 30% (P <0.05); survival rate of patients received mitral valve replacement was better than that of patients received mitral valve repair when age was over 65 years (P <0.05); no significant difference was found between mitral valve replacement and mitral valve repair groups in survival rate when left ventricular ejection fraction was less than 30% (P >0.05). 4) In the postoperative ICU, residence time, total hospital stay and cost were significantly better in mitral valve repair group. 5)Echocardiography showed that regurgitation corrective effect was significantly better in mitral valve replacement group than that of the mitral valve repair group. 6)In the rehospitalization rate, no statistically significant differences was found between the two groups. 7)Follow up of heart function in patients after operation, no significant difference was found between two groups. Conclusion 1) For the effect of correction of regurgitation, mitral valve replacement was superior to repair. 2) Operation mortality was not significantly different between two groups. The long-term survival rate of the replacement group was superior to the repair group. 3) To get better prognosis, method of surgery should be chosen based on patients' condition: when left ventricular ejection fraction is over 30%, mitral valve replacement is advised; when patient's age is over 65 years, replacement is advised; when left ventricular ejection fraction is over 30%, either method is good; If patient is young, considering the long-term anticoagulation problems, mitral valve repair is better.

Key words: ischemic mitral regurgitation, coronary artery bypass grafting, mitral valve replacement, mitral valve repair

CLC Number: